Autonomous control of terminal erythropoiesis via physical interactions among erythroid cells
- Authors
- Choi, Hye Sook; Lee, Eun Mi; Kim, Hyun Ok; Park, Moon-Il; Baek, Eun Jung
- Issue Date
- May-2013
- Publisher
- ELSEVIER SCIENCE BV
- Citation
- STEM CELL RESEARCH, v.10, no.3, pp.442 - 453
- Indexed
- SCIE
SCOPUS
- Journal Title
- STEM CELL RESEARCH
- Volume
- 10
- Number
- 3
- Start Page
- 442
- End Page
- 453
- URI
- https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/162928
- DOI
- 10.1016/j.scr.2013.02.003
- ISSN
- 1873-5061
- Abstract
- In vitro erythropoiesis has been studied extensively for its application in the manufacture of transfusable erythrocytes. Unfortunately, culture conditions have not been as effective as in vivo growth conditions, where bone marrow macrophages are known to be a key regulator of erythropoiesis. This study focused on the fact that some erythroblasts are detached from macrophages and only contact other erythroblasts. We hypothesized that additional factors regulate erythroblasts, likely through either physical contact or secreted factors. To further elucidate these critical factors, human erythroblasts derived from cord blood were cultured at high density to mimic marrow conditions. This growth condition resulted in a significantly increased erythroid enucleation rate and viability. We found several novel contact-related signals in erythroblasts: intercellular adhesion molecule-4 (ICAM-4) and deleted in liver cancer-1 (DLC-1). DLC-1, a Rho-GTPase-activating protein, has not previously been reported in erythroid cells, but its interaction with ICAM-4 was demonstrated here. We further confirmed the presence of a secreted form of human ICAM-4 for the first time. When soluble ICAM-4 was added to media, cell viability and enucleation increased with decreased nuclear dysplasia, suggesting that ICAM-4 is a key factor in contact between cells. These results highlight potential new mechanisms for autonomous control of erythropoiesis. The application of these procedures to erythrocyte manufacturing could enhance in vitro erythrocyte production for clinical use.
- Files in This Item
-
Go to Link
- Appears in
Collections - 서울 의과대학 > 서울 진단검사의학교실 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/162928)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.